328 related articles for article (PubMed ID: 20526105)
21. Metastatic colorectal cancer.
Saletti P; Cavalli F
Cancer Treat Rev; 2006 Nov; 32(7):557-71. PubMed ID: 16935430
[TBL] [Abstract][Full Text] [Related]
22. Predictive molecular classifiers in colorectal cancer.
Bohanes P; LaBonte MJ; Winder T; Lenz HJ
Semin Oncol; 2011 Aug; 38(4):576-87. PubMed ID: 21810517
[TBL] [Abstract][Full Text] [Related]
23. Personalized medicine in oncology: tailoring the right drug to the right patient.
Jiang Y; Wang M
Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
[TBL] [Abstract][Full Text] [Related]
24. Review of biomarkers in colorectal cancer.
Newton KF; Newman W; Hill J
Colorectal Dis; 2012 Jan; 14(1):3-17. PubMed ID: 21040359
[TBL] [Abstract][Full Text] [Related]
25. RNA biomarkers in colorectal cancer.
Bustin SA; Murphy J
Methods; 2013 Jan; 59(1):116-25. PubMed ID: 23079397
[TBL] [Abstract][Full Text] [Related]
26. Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.
Clarke SJ; Karapetis CS; Gibbs P; Pavlakis N; Desai J; Michael M; Tebbutt NC; Price TJ; Tabernero J
Crit Rev Oncol Hematol; 2013 Feb; 85(2):121-35. PubMed ID: 22762963
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.
De Mattia E; Cecchin E; Toffoli G
Drug Resist Updat; 2015 May; 20():39-70. PubMed ID: 26027741
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer proteomics, molecular characterization and biomarker discovery.
Barderas R; Babel I; Casal JI
Proteomics Clin Appl; 2010 Feb; 4(2):159-78. PubMed ID: 21137041
[TBL] [Abstract][Full Text] [Related]
29. Novel targets for anticancer treatment development in colorectal cancer.
Macarulla T; Ramos FJ; Capdevila J; Saura C; Tabernero J
Clin Colorectal Cancer; 2006 Nov; 6(4):265-72. PubMed ID: 17241511
[TBL] [Abstract][Full Text] [Related]
30. Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials.
Zwierzina H; Bardelli A; Ciardiello F; Gariboldi M; Håkansson L; Lambrechts D; Lind GE; Loeffler-Ragg J; Schmoll H; Siena S; Tabernero J; Van Cutsem E
Curr Opin Mol Ther; 2010 Dec; 12(6):703-11. PubMed ID: 21154162
[TBL] [Abstract][Full Text] [Related]
31. The role of tumor markers and biomarkers in colorectal cancer.
Lech G; Slotwinski R; Krasnodebski IW
Neoplasma; 2014; 61(1):1-8. PubMed ID: 24195503
[TBL] [Abstract][Full Text] [Related]
32. Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer.
Hansen TF; Jakobsen A
Pharmacogenomics; 2011 Dec; 12(12):1681-93. PubMed ID: 22118052
[TBL] [Abstract][Full Text] [Related]
33. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
34. Treatment advances in liver-limited metastatic colorectal cancer.
Alberts SR; Poston GJ
Clin Colorectal Cancer; 2011 Dec; 10(4):258-65. PubMed ID: 21820974
[TBL] [Abstract][Full Text] [Related]
35. Development of novel targeted agents in the treatment of metastatic colorectal cancer.
Berge E; Thompson C; Messersmith W
Clin Colorectal Cancer; 2011 Dec; 10(4):266-78. PubMed ID: 21903484
[TBL] [Abstract][Full Text] [Related]
36. Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances.
Lech G; Słotwiński R; Słodkowski M; Krasnodębski IW
World J Gastroenterol; 2016 Feb; 22(5):1745-55. PubMed ID: 26855534
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer: how emerging molecular understanding affects treatment decisions.
Sridharan M; Hubbard JM; Grothey A
Oncology (Williston Park); 2014 Feb; 28(2):110-8. PubMed ID: 24701697
[TBL] [Abstract][Full Text] [Related]
38. Links between biology, prognosis and prediction of response to chemotherapy in colorectal cancer.
Mader RM
Onkologie; 2006 Jul; 29(7):334-41. PubMed ID: 16874019
[TBL] [Abstract][Full Text] [Related]
39. Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives.
Custodio A; Barriuso J; de Castro J; Martínez-Marín V; Moreno V; Rodríguez-Salas N; Feliu J
Cancer Treat Rev; 2013 Dec; 39(8):908-24. PubMed ID: 23510598
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic biomarkers in colorectal cancer diagnostics.
Rawson JB; Bapat B
Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
